Meritage Portfolio Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,266
Closed -$398K 337
2023
Q2
$398K Buy
31,266
+9,306
+42% +$116K 0.03% 263
2023
Q1
$247K Buy
21,960
+921
+4% +$11.2K 0.02% 281
2022
Q4
$279K Buy
21,039
+511
+2% +$6.72K 0.02% 261
2022
Q3
$238K Buy
20,528
+1,664
+9% +$22.8K 0.02% 271
2022
Q2
$278K Buy
+18,864
New +$309K 0.02% 258
2019
Q1
Sell
-287,897
Closed -$5.02M 192
2018
Q4
$5.02M Sell
287,897
-6,685
-2% -$109K 0.57% 57
2018
Q3
$4.49M Sell
294,582
-2,146
-0.7% -$30.9K 0.41% 113
2018
Q2
$4.09M Buy
296,728
+5,457
+2% +$81.8K 0.4% 110
2018
Q1
$4.86M Buy
+291,271
New +$4.5M 0.47% 90

Other funds holding INVA

Meritage Portfolio Management's INVA Position: Q3 2023 in Review

Meritage Portfolio Management sold out of Innoviva (INVA) in Q3 2023, closing a stake of 31,266 shares — an estimated $398K sold.

Meritage Portfolio Management first reported a position in INVA in Q1 2018 and held it in 9 quarters. The position peaked at $5.02M in Q4 2018. 193 funds tracked by Wall St. Rank hold INVA as of Q3 2023.

  • Meritage Portfolio Management reported no remaining Innoviva position as of Q3 2023 after selling out during the quarter.
  • Meritage Portfolio Management sold 31,266 Innoviva shares in Q3 2023, an estimated $398K.
  • Meritage Portfolio Management first reported a position in Innoviva in Q1 2018 and held it in 9 quarters.
  • Meritage Portfolio Management's Innoviva position peaked at $5.02M in Q4 2018.
  • 193 funds tracked by Wall St. Rank held Innoviva as of Q3 2023.

Based on Meritage Portfolio Management's 13F filing for Q3 2023, filed 30 Oct 2023.